Skip to content

Advance Care Planning Individualised Approach and Research Projec

The AIR Project - Advance Care Planning Individualised Approach and Research Project. A Single Center Randomized Controlled Trial

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03915743
Acronym
AIR
Enrollment
10
Registered
2019-04-16
Start date
2019-05-01
Completion date
2020-11-01
Last updated
2021-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe COPD

Keywords

Palliative care, Out-patient clinic, COPD symptom burden

Brief summary

The study will investigate the effect of a palliative approach in the out-patient management of patients with COPD.

Detailed description

Randomised control trial. A total of 90 patients will be randomise 1:1 to either palliative intervention or standard care. The intervention group will receive follow up in a newly established outpatient clinic for COPD in the specialized palliative united and the control group will receive standard follow up in the respiratory out-patient clinic.

Interventions

OTHERpalliative care

complex and multi-faceted individualized palliative care

Sponsors

Herlev and Gentofte Hospital
Lead SponsorOTHER
Hvidovre University Hospital
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

RCT

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* • Diagnosis of COPD by spirometry * Patients followed in Herlev and Gentofte hospitals' respiratory out-patient-clinics or admitted to Herlev or Gentofte hospital for acute exacerbation * 2 or more admissions for acute exacerbation of COPD within the last 12 months * CAT \> 20 * Cognitive and linguistic able to understand and give informed consent

Exclusion criteria

* • Expected remaining life time less than 6 months due to other disease than COPD e.g. active cancer * Participating in other studies

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline in total Hospital and Anxiety Depression scale (HADS) at 6 monthsbaseline, 3 and 6 monthsquestionnaire measuring anxiety and Depression in 2 subscales in this study we use the total value of the 2 subscales combined. The higher the number the worse the psychological impact. HADS total was a range from 0 to 24 where 0 is no psychological distress

Secondary

MeasureTime frameDescription
Change from Baseline EORTC QLQ-C15-PAL at 6 monthsbaseline, 3 and 6 monthsquestionnaire, consists of 14 questions and a license audit goal from 1 to 7 where 7 is the best possible quality of life.For the first 14 questions about symptoms, the scale goes from 1 to 4 where 4 is the worst
Change from Baseline Life-Space Assessment (LSA) at 6 monthsbaseline, 3 and 6 monthsquestionnaire,5 questions about where the patient has been in the last 4 weeks. Question 1 is other than bedroom and question 5 is out of his home town. In addition, questions are asked about how frequently and on the use of aids.finally the scales are converted to numerical value between 0 and 120 where 0 is worst and expresses that the patient is constant in bed
Change from Baseline copd assessment test (CAT) at 6 monthsbaseline, 3 and 6 monthsquestionnaire. 8 items questionnaire where there should be between 0 and 5 where 5 is the worst. Together, this gives a total scale between 0 and 40 where 40 is worst

Other

MeasureTime frameDescription
Change from Baseline Use of out-patient clinic at 6 monthsbaseline to 6 monthsnumber of out-patient clinic visits
Change from Baseline in admission frequency at 6 monthsbaseline to 6 monthnumbers of admissions in the study periode
Adherence at 6months6 monthsmeasured by inhaled medicine bought at the pharmacy. Data is gather from a national database

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026